Wavelength Intervention for Nearsighted Kids
University of Alabama at Birmingham · with National Eye Institute (NEI) · NCT06598423
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 7–12 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- April 10, 2025
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if daily brief periods of specialized soft contact lens wear work to slow the progression of nearsightedness in children. Additionally, the study will learn about the compliance and safety of specialized soft contact lens wear in children. The main questions it aims to answer are:
Does wearing specialized soft contact lenses daily slow myopia progression and axial elongation? What visual/ocular problems do participants have when wearing specialized soft contact lenses? Researchers will compare two soft contact lenses to see if specialized soft contact lens wear works to treat childhood myopia progression.
Participants will
- Wear either a single type of soft contact lens or two types of soft contact lenses at alternate times daily full time in both eyes for one year.
- Visit the clinic at 2 weeks, 1 month, 3 months, 6 months, and 12 months for checkups and tests
- Keep a diary of the lens-wearing times.
Being studied: Specialized soft contact lens 1; Specialized soft contact lens 2
Conditions: Myopia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Spherical component of refractive error in primary meridian between -0.75 and -5.00 D
- Less than 1.00 D of astigmatism or anisometropia
- History of soft contact lens wear for at least a week
- Best-corrected visual acuity of 20/25 (+0.10 logMAR) or better in each eye
- Willingness to wear the lenses for a minimum of 10 hours/day, at least six days a week for the duration of the study
Exclusion Criteria
- Subjects receiving myopia control treatments within the past six months
- History of premature (less than 3.3 lb) or preterm birth (earlier than 30 weeks)
- Current history of using systemic or ocular medications (including artificial tears) that may affect contact lens wear, tear film health, refractive state, pupillary response or accommodative function
- History of ocular or systemic diseases, including those that may affect refractive development
- Known allergy to fluorescein, benoxinate, proparacaine, or tropicamide
- Contact lens contraindications (e.g., giant papillary keratoconjunctivitis)
- Corneal disorders (e.g., hypoesthesia, keratoconus)
- Strabismus at distance or near with distance glasses or contact lenses
- Subjects exhibiting poor personal hygiene that may affect the compliance of contact lens wear.
Recruiting US locations
University of Alabama at Birmingham School of Optometry
Birmingham, AL 35233
Site contact: Safal Khanal, OD, PhD · 205.934.4558 · skhanal@uab.edu
Study contacts (from the official record)
- Sindhu Gurrala, MPH · 205.975.3881 · sgurral2@uab.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65